Neuroone Medical Technologies (NMTC) Non Operating Interest Expenses (2011 - 2016)

Neuroone Medical Technologies (NMTC) has reported Non Operating Interest Expenses for 5 consecutive years, with $4250.0 the latest figure, recorded in Q1 2016.

• For the quarter ending Q1 2016, Non Operating Interest Expenses fell 63.31% year-over-year to $4250.0; the trailing twelve-month figure through Mar 2016 stood at $15105.0 (up 43.42% YoY), and the FY2021 full-year result was $3053.0, changed N/A from the prior year.
• Non Operating Interest Expenses retreated to $4250.0 in Q1 2016 per NMTC's latest filing, from $11583.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $11583.0 in Q1 2015 and bottomed at -$401.0 in Q3 2013.
• Historically, Non Operating Interest Expenses has averaged $1617.2 across 4 years, with a median of -$58.0 in 2012.
• The sharpest annual moves came in 2012 and 2013: Non Operating Interest Expenses climbed 5.77% in 2012, then plunged 718.37% in 2013.
• Over 4 years, Non Operating Interest Expenses stood at -$58.0 in 2012, then sank by 591.38% to -$401.0 in 2013, then surged by 2988.53% to $11583.0 in 2015, then tumbled by 63.31% to $4250.0 in 2016.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $4250.0, $11583.0, and -$401.0 for Q1 2016, Q1 2015, and Q3 2013 respectively.